Navigation Links
Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executive Officer
Date:7/10/2008

FORT LAUDERDALE, Fla., July 10 /PRNewswire-FirstCall/ -- Synovics Pharmaceuticals, Inc. (OTC Bulletin Board: SYVC), a specialty pharmaceutical company, today announced that Mr. Jyotindra Gange, has been appointed Principal Executive Officer of the Company and in such capacity given the responsibility of overseeing all executive functions. Mr. Gange is currently a member of Synovics' board of directors and is the Chief Financial Officer of Maneesh Pharmaceuticals, LTD., a leading privately held pharmaceutical company based in India and a joint venture partner with Synovics. Maneesh Pharmaceuticals LTD. is a significant investor in Synovics Pharmaceuticals, Inc. Previously, Mr. Gange served as Chief Financial Officer of Multi Arc India Ltd., a provider of industrial coatings and Bharat Serums and Vaccines Ltd., an Indian pharmaceuticals company. Mr. Gange was also Vice President - Finance at Universal Ferrous Ltd., a producer of ferro alloys. Mr. Gange is a Chartered Accountant in India. Ronald Howard Lane, Ph.D., resigned as the Company's Chief Executive Officer and will remain as its Chairman of the Board.

"We are very pleased to announce the appointment of Mr. Gange as Principal Executive Officer," stated Dr. Lane. "This step is part of an ongoing series of planned undertakings by our board that are intended to position the Company for growth and give it the capacity to access the advantages represented by our 'Front-End' strategy with India pharmaceutical companies. Mr. Gange brings a wealth of experience to Synovics, both financial and operational, and the board expects that he will make a significant impact on our development and business."

"I am excited about the potential Synovics Pharmaceuticals represents, in both prescription and over-the counter (OTC) drug markets," commented Mr. Gange. "Our current product mix and pharmaceutical licenses provides a wonderful foundation for this Company. The management team in the operating businesses
'/>"/>

SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
2. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
3. Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Diego School of Medicine report that older women, plucky ... loss are more likely to be compassionate toward strangers ... in this month,s issue of the International Journal ... associated with better health and well-being as we age, ... the outcomes of individuals whose deficits in compassion put ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
(Date:4/17/2014)... (April 17, 2014) Doctors who treat patients ... lymphangioleiomyomatosis (LAM) can face an agonizing treatment decision. ... the disease and help relieve shortness of breath. ... and sirolimus can cause potentially fatal complications following ... Dr. Daniel Dilling, medical director of Loyola University ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit ... issues, published a comprehensive review today examining the current ... virus. The review calls for improved global surveillance strategies ... the recent outbreak of Ebola in West Africa that ... countries of Guinea and Liberia. According to the ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... Wrigley told the jurors that Dru Sjodin, 22, struggled for ... Rodriguez Jr. was the man responsible for her death.// ... has pleaded not guilty to a charge of abduction resulting ... of North Dakota. According to prosecutors, death penalty will be ...
... are hairier than others may have been discovered, according to ... embryonic skin cells will form into hair follicles, deciding the ... the University of Manchester. ,This study on mice ... -- a range of conditions in which skin cells fail ...
... be wary of the so-called stem cell wonder cures that ... tested.// ,The health experts had yesterday in a ... a world leader in stem cell research, but cautioned that ... cosmetic skin treatment were yet to be proven, and could ...
... from Johns Hopkins and made available on the World Wide ... to cilia operations in the body. // ,The researchers ... structures on the surface of cells called cilia as such ... 'orphaned diseases' all have links associated with the tiny, hair-like ...
... Paisley and the Raigmore in Inverness do not maintain hygiene ... Scotland. ,The study categorized hospitals by traffic light ... the set standards, amber for hospitals in the 70% and ... ERI, the rate was 84.1%, while Raigmore scored 83.1% and ...
... Institute of Virology in Pune declared Tuesday there is no ... from here in south Gujarat.// ,Additional director of ... Surat city, and not even a single sample contained Hantavirus." ... not yet clarified why two persons had died last week. ...
Cached Medicine News:Health News:The fate of an accused in a murder case to be decided 2Health News:Scientists In UK Issue A Caution Over Untested Stem Cell Treatments 2Health News:John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases 2Health News:John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases 3
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... Pa., Oct. 29 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today ... Credit Suisse Healthcare Conference to be held November 10-12, 2010 ... Fickenscher, Chief Financial Officer, is scheduled to present an overview ... ET on Thursday, November 11, 2010. To listen ...
... Calif., Oct. 28 VIVUS, Inc. (Nasdaq: ... Response Letter (CRL) from the U.S. Food and Drug ... the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The ... the NDA cannot be approved in its present form. ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 2Auxilium Pharmaceuticals to Present at the 2010 Annual Credit Suisse Healthcare Conference 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 2FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 3FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 4FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA® 5
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: